Literature DB >> 17142753

Semimature stage: a checkpoint in a dendritic cell maturation program that allows for functional reversion after signal-regulatory protein-alpha ligation and maturation signals.

Deborah Braun1, Laurent Galibert, Toshiharu Nakajima, Hirohisa Saito, Van Vu Quang, Manuel Rubio, Marika Sarfati.   

Abstract

CD47 on live cells actively engages signal-regulatory protein-alpha (SIRP-alpha) on phagocytes and delivers a negative signal that prevents their elimination. We evaluated the biological consequences of SIRP-alpha ligation on the dendritic cell (DC) response to maturation signals and the potential interplay with the IL-10/IL-10R inhibitory pathway. At first, CD47/SIRP-alpha allowed the generation of mature migratory DCs not producing IL-12, IFN-gamma-inducible protein-10, and CCL19. Rather, they secreted neutrophils attracting chemokine CXCL5 and IL-1beta, reflecting a partial block in functional DC maturation. Afterward, semimature DCs functionally regressed in an IL-10-independent fashion toward cells that retrieved the cardinal features of immature DCs: re-expression of CCR5, loss of DC-lysosome-associated membrane protein, high endocytosis, and impaired allostimulatory functions. The global gene expression profile of IL-10 and SIRP-alpha-ligated DC demonstrated two distinct molecular pathways. IL-10R and SIRP-alpha expression were reciprocally down-regulated by CD47 and IL-10, respectively. These results emphasize that the SIRP-alpha pathway might be part of the molecular machinery used by the DC to dampen or resolve an inflammatory response in an IL-10-independent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142753     DOI: 10.4049/jimmunol.177.12.8550

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  CD47 in xenograft rejection and tolerance induction.

Authors:  Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

2.  Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.

Authors:  Zhenyu Xiao; Haniee Chung; Babak Banan; Pamela T Manning; Katherine C Ott; Shin Lin; Benjamin J Capoccia; Vijay Subramanian; Ronald R Hiebsch; Gundumi A Upadhya; Thalachallour Mohanakumar; William A Frazier; Yiing Lin; William C Chapman
Journal:  Cancer Lett       Date:  2015-02-23       Impact factor: 8.679

3.  Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.

Authors:  Sohel M Julovi; Barkha Sanganeria; Nikita Minhas; Kedar Ghimire; Brian Nankivell; Natasha M Rogers
Journal:  Lab Invest       Date:  2020-05-04       Impact factor: 5.662

4.  CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing.

Authors:  Chao Wang; Nicole F Steinmetz
Journal:  Adv Healthc Mater       Date:  2019-03-06       Impact factor: 9.933

5.  Survival and function of CD47-deficient thymic grafts in mice.

Authors:  Yuantao Wang; Hui Wang; Shumei Wang; Yaowen Fu; Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Mar-Apr       Impact factor: 3.907

6.  Human uterine epithelial cell secretions regulate dendritic cell differentiation and responses to TLR ligands.

Authors:  Daniel O Ochiel; Mimi Ghosh; John V Fahey; Paul M Guyre; Charles R Wira
Journal:  J Leukoc Biol       Date:  2010-04-12       Impact factor: 4.962

7.  Rapid dendritic cell activation and resistance to allotolerance induction in anti-CD154-treated mice receiving CD47-deficient donor-specific transfusion.

Authors:  Yuantao Wang; Hui Wang; Roderick Bronson; Yaowen Fu; Yong-Guang Yang
Journal:  Cell Transplant       Date:  2013-01-02       Impact factor: 4.064

8.  CD47 is required for suppression of allograft rejection by donor-specific transfusion.

Authors:  Hui Wang; Xiaojian Wu; Yuantao Wang; Per-Arne Oldenborg; Yong-Guang Yang
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

9.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

10.  Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus.

Authors:  JiChu Li; JooHung Park; Deborah Foss; Irving Goldschneider
Journal:  J Exp Med       Date:  2009-03-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.